Thomson Reuters has announced the launch of Precision Medicine Intelligence, an evidence-based solution aimed at scientists and physicians. The solution is delivered via an API and through partner platforms.
The intelligence solution provides a structured database of evidence-based clinical outcomes, and supports patient segment definition and stratification for clinical research.